PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--ForteBio®, a division of Pall Life Sciences (NYSE: PLL) and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the introduction of its Dip and Read™ Ni-NTA biosensor for use on its Octet® and BLItz™ instrumentation platforms. The new biosensor is pre-immobilized with novel nickel-charged tri-nitrilotriacetic (Tri-NTA) groups enabling an easy, rapid and direct method for quantitation and kinetic analysis of polyhistidine-tagged (HIS-tagged) biomolecules.
